157 related articles for article (PubMed ID: 36387072)
1. The involvement of high succinylation modification in the development of prostate cancer.
Zhang Z; Chen Y; Fang L; Zhao J; Deng S
Front Oncol; 2022; 12():1034605. PubMed ID: 36387072
[TBL] [Abstract][Full Text] [Related]
2. Protein succinylation associated with the progress of hepatocellular carcinoma.
Bai W; Cheng L; Xiong L; Wang M; Liu H; Yu K; Wang W
J Cell Mol Med; 2022 Nov; 26(22):5702-5712. PubMed ID: 36308411
[TBL] [Abstract][Full Text] [Related]
3. Histone lysine methylation patterns in prostate cancer microenvironment infiltration: Integrated bioinformatic analysis and histological validation.
Quan Y; Zhang X; Wang M; Ping H
Front Oncol; 2022; 12():981226. PubMed ID: 36237332
[TBL] [Abstract][Full Text] [Related]
4. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation.
Quan Y; Zhang X; Ping H
Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
[TBL] [Abstract][Full Text] [Related]
6. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP
Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696
[TBL] [Abstract][Full Text] [Related]
7. Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model.
Zhang Y; Zhang R; Liang F; Zhang L; Liang X
Front Oncol; 2020; 10():598801. PubMed ID: 33324566
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the lysine succinylome in fish oil-treated prostate cancer cells.
Jiang Y; He C; Ye H; Xu Q; Chen X; Chen Y; Sun J; Rocha S; Wang M
Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37684043
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. RRBP1 is highly expressed in prostate cancer and correlates with prognosis.
Li T; Wang Q; Hong X; Li H; Yang K; Li J; Lei B
Cancer Manag Res; 2019; 11():3021-3027. PubMed ID: 31118771
[No Abstract] [Full Text] [Related]
11. Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer.
Li X; Zhang C; Zhao T; Su Z; Li M; Hu J; Wen J; Shen J; Wang C; Pan J; Mu X; Ling T; Li Y; Wen H; Zhang X; You Q
J Exp Clin Cancer Res; 2020 Aug; 39(1):172. PubMed ID: 32859246
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J
Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198
[TBL] [Abstract][Full Text] [Related]
13. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of lysine succinylation of the human pathogen Histoplasma capsulatum.
Xie L; Li J; Deng W; Yu Z; Fang W; Chen M; Liao W; Xie J; Pan W
J Proteomics; 2017 Feb; 154():109-117. PubMed ID: 28063982
[TBL] [Abstract][Full Text] [Related]
15. Chromatin Succinylation Correlates with Active Gene Expression and Is Perturbed by Defective TCA Cycle Metabolism.
Smestad J; Erber L; Chen Y; Maher LJ
iScience; 2018 Apr; 2():63-75. PubMed ID: 29888767
[TBL] [Abstract][Full Text] [Related]
16. Identification of lysine succinylation as a new post-translational modification.
Zhang Z; Tan M; Xie Z; Dai L; Chen Y; Zhao Y
Nat Chem Biol; 2011 Jan; 7(1):58-63. PubMed ID: 21151122
[TBL] [Abstract][Full Text] [Related]
17. Identification of Prognostic Genes in Hepatocellular Carcinoma.
Bai W; Cheng L; Xiong L; Wang M; Liu H; Yu K; Wang W
Int J Gen Med; 2022; 15():2895-2904. PubMed ID: 35300146
[TBL] [Abstract][Full Text] [Related]
18. Inspector: a lysine succinylation predictor based on edited nearest-neighbor undersampling and adaptive synthetic oversampling.
Zhu Y; Jia C; Li F; Song J
Anal Biochem; 2020 Mar; 593():113592. PubMed ID: 31968210
[TBL] [Abstract][Full Text] [Related]
19. Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer.
Bamodu OA; Wang YH; Yeh CT; Ho CH; Chiang YT; Kao WT; Liu CH; Wu CC
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572412
[TBL] [Abstract][Full Text] [Related]
20. A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer.
Ke ZB; You Q; Sun JB; Zhu JM; Li XD; Chen DN; Su L; Zheng QS; Wei Y; Xue XY; Xu N
Front Cell Dev Biol; 2021; 9():774625. PubMed ID: 35071228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
